share_log

Novavax | 144: Notice of proposed sale of securities pursuant to Rule 144

Novavax | 144: Notice of proposed sale of securities pursuant to Rule 144

諾瓦瓦克斯醫藥 | 144:擬議出售證券
美股SEC公告 ·  09/19 04:12

牛牛AI助理已提取核心訊息

Novavax Inc officer Filip Dubovsky is set to sell 7,335 shares of common stock on 09/18/2024, as per the latest filing. The shares, valued at an aggregate market value of $95,331, were acquired on the same date through stock plan activity directly from the issuer. This transaction follows a period where no other sales were reported in the past three months. The planned sale is part of a pre-arranged trading plan adopted on 06/18/2024.
Novavax Inc officer Filip Dubovsky is set to sell 7,335 shares of common stock on 09/18/2024, as per the latest filing. The shares, valued at an aggregate market value of $95,331, were acquired on the same date through stock plan activity directly from the issuer. This transaction follows a period where no other sales were reported in the past three months. The planned sale is part of a pre-arranged trading plan adopted on 06/18/2024.
諾瓦瓦克斯公司高管Filip Dubovsky計劃於2024年09月18日賣出7335股普通股,根據最新提交的文件。這些股票的總市值爲95331美元,是通過股票計劃活動直接從發行人處於同一日期獲得的。該交易是在過去三個月沒有其他銷售報告的情況下進行的。計劃的銷售是在2024年06月18日採納的預先安排的交易計劃的一部分。
諾瓦瓦克斯公司高管Filip Dubovsky計劃於2024年09月18日賣出7335股普通股,根據最新提交的文件。這些股票的總市值爲95331美元,是通過股票計劃活動直接從發行人處於同一日期獲得的。該交易是在過去三個月沒有其他銷售報告的情況下進行的。計劃的銷售是在2024年06月18日採納的預先安排的交易計劃的一部分。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。